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The present study aimed to evaluate the safety of the alcoholic leaves extract of Reinwardtia indica 
in Charles foster rats through an acute and sub-acute oral administration.For assessment of acute oral 
toxicity test, ratswere orally treated with single dose of the alcoholic leaves extract of Reinwardtia indica 
at the doses of 50, 250, 500, 1000 2000 and 5000 mg/kg. In sub-acute toxicity study, using the OECD 
guidelines no. 407, the extract was administered at the doses of 50, 250, 500, 1000, 2000 mg/kg/day for 
28 consecutive days and at the dose of 2000 mg/kg satellite group also used for 6 weeks.In acute toxicity 
above mentioned doses neither showed mortality nor exterior signs of toxicity. In sub-acute, study no 
significant changes found in haematological and biochemical level ofthe treated rat after 14 days and 
28 days in comparison to control. The histopathology of rat brain, kidney, liver, and heart also showed 
the no cellular changes after extract treated rat.The alcoholic leaves extract of Reinwardtia indica was 
found non-toxic in single drug dose administration up to 5000 mg/kg (acute study) and in sub-acute 
administration up to 2000 mg/kg.
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INTRODUCTION 
Reinwardtia indica Dumort is commonly known 
as Pyoli, Basanti, phunili, shivali etc.It belongs to the 
Linaceaefamily and found in the Himalayan region of 
India, Nepal, and China and the Western Ghats. Only 
three species of Reinwardtia, are known which are native 
to Southern Asia namely Reinwardtia indica (Rawat et 
al., 2015), Reinwardtia trigyna (Perveen, Qaiser, 2008) 
and Reinwardtia sinensis (Quanru, Zhou, 1998). In India, 
the genus is represented by only one species i.e.R. indica, 
native of Himalayan foothills found in a wide altitudinal 
range of 500-2500 masl. It is used as folk medicine in 
India;traditionally people used the plant for the treatment 
of boils, pimples, skin infection and carbuncle. The bright 
yellow petals of the plant were used for tongue wash 
whereas the crushed leaves were used to treat paralysis 
as its chemical component would act upon the sodium 
pump. The stem paste was used as wound healer in cattle’s 
when affected by maggots (Pande, Tiwari, Pandel, 2007). 
The plant is also used to increase the lactation period 
and its flower is used as a dye for clothes.The paste of 
the whole plant is used to get relief from backaches 
(Malla, Gauchan, Chhetri, 2014; Sidhu, Thakur, 2016). 
It is used in traditional Chinese medicine formulation 
for the treatment of acute or chronic gastritis (Cn, 2014a; 
2014b). Reinwardtia trigyna is used as natural herbicide 
and weedicide as it showed a good phytotoxic activity 
(Khan et al., 1998; Perveen, Qaiser, 2008; Abha, Swati, 
Shukla, 2013). The reported pharmacological activity of 
the other plants belong to the same family (flax family) 
are used as antioxidant, wound healing, anti-microbial, 
anti-inflammatory, and anti-nociceptive agent. Medicinal 
properties of the plant are due to the presence of alkaloids, 
flavonoids, phenolic, tannins and other phytoconstituents. 
Several reports have demonstrated that secondary plant 
metabolites exert diverse medicinal biological effects 
(Saleem et al., 2005). In ultra-performance liquid 
chromatography mass-spectrometry (UPLCMS-MS) of 
the extract showed several essential phyto-molecules 
belongs to flavonoid class, reported in the treatment and 
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management of lifestyle related disease or disorders like, 
neurodegenerative, anti-depressant, cancer, anti-diabetic, 
metabolic disorders etc. (manuscript submitted). The aim 
of this study was to assess the acute and sub-acute toxicity 
study in Charles foster rats at different dose level with 
haematological and biochemical estimation from blood 
and histopathology of brain, kidney, heart & liver after 
14th & 28th days.
MATERIAL AND METHODS
Plant material and preparation of extracts
R. indica was collected from Uttrakhand (2000-
2200 m altitude) the surroundings of the region of the 
Himalayan in the month of September to February. Plants 
were flowering in winter (Paudel Chhetri et al., 2008; Bhat, 
Kumar, Bussmann, 2013). The specimen of plant part 
leaves and stem were identified at the Herbarium (Voucher 
specimen number Lina.2015/1) of the Department of 
Botany, Institute of Science by Professor N. K. Dubey. 
Leaves were washed thoroughly under running tap water, 
oven dried at 50–600C for two days finely ground using 
an electric blender and stored in plastic containers at room 
temperature and in darkness until required for use. For the 
preparation of extract, the powdered sample of leaves (100 
g) were extracted by using a Soxhletapparatus with hot 
percolationmethodand absolute ethanol (250 ml) was used 
as a solvent. The extract was then filtered and evaporated 
to dryness at a 45oC with a rotary evaporator (Buchi R-210 
Advanced, Switzerland) and named as AERI. 
Experimental design
Animals
The protocol of this study was approved by 
Institutional Animal Ethical Committee of Institute of 
Medical Sciences (BHU Varanasi, India). The inbreed 
albino female rats of Charles foster strain (120-150 g) 
was purchased from the Central Animal Facility of our 
Institute and acclimatized in our laboratory conditions for 
7 days with free access to normal standard chow diet and 
tap water. They were maintained under standard conditions 
of temperature (23±2 °C) and a relative humidity of 50%. 
Acute toxicity
The oral acute toxicity study was carried out 
according to the guideline Nr. 423 provided by the 
Organization of Economic Cooperation and Development 
(OECD) for the acute toxicity class method (ATC) 
procedure with slight modifications. Prior to administration 
of treatment, animals were weighed, marked and fasted 
overnight without suppression of water. Animals of the 
control group received distilled water whereas the treated 
groups received a single dose of 50, 250, 500, 1000, 2000 
and 5000 mg/kg body weight of the alcoholic extract 
of Reinwardtia indica leaves (AERI) freshly prepared. 
After dosing, food was with held for a further 3–4 h while 
animals were observed individually for clinical signs of 
toxicity such as mortality, respiratory pattern, changes 
in general behaviour, skin, eyes, fur and somatomotor 
activity. 
Sub-acute toxicity study
According to the OECD guidelines no. 407 with 
slight modification, rats were divided into 6 groups of 6 
animals and treated by gavage. Control group received 
distilled water while, the AERI treated groups received 
the extract once daily (10:00–1:00 pm) for 28 consecutive 
days at the doses of 50, 250, 500, 1000 and 2000 mg/kg. 
Satellite group at the dose of 2000 mg/kg also used for 
6weeks to observe the effect of extract in animals.
Body weight, food and water consumption
Body weights of the rat in all groups were recorded 
before administration of doses, further body weight 
was taken weekly entire treatment and finally on the 
day of sacrifice. The amount of food and water intake 
was recorded daily. The consumed amount of food and 
water were measured before provide to each group, their 
remnants were calculated next day to get the differences, 
which were recorded as daily food (gm./rat/day) and water 
consumption (ml/rat/day).
Blood analysis
Blood samples were collected from the retro-orbital 
region of the rats for measurement of haematological 
(EDTA-coated tubes) and biochemical (dry tubes) 
parameters after 14 days and 28 days.
Hematological analysis
The blood samples collected in heparinized tubes 
were used for the hematological analyses. The following 
parameters: red blood cell count (RBC), white blood 
cell count (WBC), neutrophils (NP), lymphocytes 
(LC), monocytes (MC), eosinophils (EP), hemoglobin 
(Hb), platelets (PL) and packed cell volume (PCV) by 
automated analyzer (KX-21-Hematology-analyzer, 
SysmexCorporation, USA).
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Biochemical analysis
Dry tubes containing collected blood were centrifuged 
at 3000 rpm at 25 °C for 15 min to obtain the serum, 
which was stored at -20 °C until the measurement of 
biochemical parameters (Erbachem 5 semi-auto analyzer).
Serum glutamic oxaloacetic transaminase (SGOT), Serum 
glutamic pyruvic transaminase (SGPT) (Coral clinical 
system), Alkaline phosphatase (ALP) (Arkray health care 
Pvt. ltd.), Urea, Creatinine (Coral clinical system) and BUN.
Histological analysis
Organs such as heart, liver, kidneys, and brain were 
excised and fixed in 10% formaldehyde for histological 
analysis. Paraffin-embedded organs were cut into 5 mm 
sections and stained with hematoxylin and eosin. Stained 
sections were visualized and all measurements performed 
using a Nikon eclipse e200 microscope equipped with 
cat cam 300-3.0MP micro cope cameraconnected to a 
computer where the images were transferred and analyzed 
with the Scope Tek scope photo x86, 3.1.475. 
Dose estimation
The toxicity study was performed according to 
OECD guideline 407 and 423 up to 5000 mg/kg for acute 
and in sub-acute 2000 mg/kg body wt. of the extract. 
Extract showed no significant toxicity in physiology, 
biochemical and histopathology of the animal. For in 
vivo biological activity the estimated dose for animals 
may be 1/10th or 1/20th of maximum dose from toxicity 
assessment study. The human daily dose is estimated by 
body surface conversion and using the formula: 
Human equivalent dose (HED) = Animal dose (mg/kg) 
X Animal Km/Human Km
Statistical analysis
Data are expressed as mean ± standard error of the 
mean (SEM). Comparison and analysis were performed 
using the one way ANOVA one way variance followed 
by Dunnett’s multiple comparisons. The p values <0.001 
were considered as significant.
RESULTS AND DISCUSSION
Before pharmacological study of any medicinal 
plant, the acute and sub-acute toxicity is the mandatory 
requirement as per the standard guideline and to develop 
the phytopharmaceutical product (Parasuraman, 2011). It 
is also the process of dose determination at the pre-clinical 
level in drug discovery and development process (Zhang et 
al., 2012). Reinwardtia indica is the novel medicinal plant 
used as a folk medicine in the treatment and management 
of several diseases on the basis of traditional uses but no 
scientific report available till today. First, we standardized 
the plant materials, evaluated the anti-oxidant, anti-
microbial activity and profiling the phytochemical through 
UPLCMS-MS (paper submitted), further assess the acute 
and sub-acute studies in animal first time. 
Acute toxicological evaluation
To assess the acute toxicity of AERI, female rats were 
orally treated single days with various concentrations (50, 
250,500, 1000, 2000 and 5000 mg/kg) of AERI for one day. 
Mortality, clinical signs, temperature, change in skin, eye 
colour change, food intake, general physique, diarrhoea, 
sedation were recorded. There were no treatment-related 
mortalities in any groups. Additionally, none of the rats 
treated with single days AERI displayed remarkable 
changes in clinical observations during study period 
however at higher doses (2000 mg/kg & 5000 mg/kg) 
animals were showed the sedation (Table I). 
Sub-acute toxicity
Specifically assess the sub-acute toxicity rats were 
sorted into six groups and treated with control 50, 250, 
500, 1000, 2000 mg/kg/day for 4 weeks and satellite 
dose 2000 mg/kg/day for 6 weeks. Body weight, intake 
of food & water, hematology, serum chemistry and 
microscopic findings were recorded after 2 weeks and 
4 weeks. In satellite treated group, the intake of food,water 
consumption, hematology and biochemical were assessed 
after 6 weeks.
Effect of AERI on body weight, food intake and 
water consumption in rats
After 28 days of oral administration, the food intake 
and water consumption were also not affected.It indicates 
that the extract did not induce appetite suppression and 
deleterious effects on growth of rats. Normal health of rats 
suggested that no significant changes were observed in 
their physiological as well as metabolic activity. However, 
in some sub-acute studies of the extract, these changes 
were observed due to the extract treatment at several 
doses which influenced the food and water intake of rat. 
The negative effect of the extract showed at the particular 
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dose toxicity in rat (Koumba Madingou et al., 2016). But 
during dosing (28-day) and the recovery periods, there was 
no significant change in food and water intake i at different 
dose treated groups as compared to their respective 
control (Table II). In satellite group, also rat treated with 
the highest dose (2000mg/kg b. wt.) did not show any 
significant change in food uptake and water intake.
Effect of AERI on haematological parameters 
The study of haematological parameters indicates 
the toxic effects of the extract on the blood of rats due to 
changes in physiological or pathological level. Blood is 
the essential medium for transport of nutrients and foreign 
bodies in the body. If extract shows the toxicity in the 
body, it directly affects its components such as red blood 
cells, white blood cells, platelets and haemoglobin. The 
ranges of these components either decrease or increase 
significantly from normal.It indicated that the toxicity 
caused by the extract which can also affect the body 
immune as well function of organs (Uddin et al., 2014). 
Data of haematological analysis of 14th and 28th days were 
given in Table III and Table IV. Results revealed that no 
significant changes have been shown in the haematological 
analysis when compared with control. The same result also 
found in the satellite treated group.
Effect of AERI on biochemical parameters
The body has two essential and vital organs for 
proper function are liver and kidney. The function of liver 
and kidney are different one is used for metabolism of 
intake and other one is used for excretion of waste product. 
To assess the toxicity of any new compound it is necessary 
to know the status of these two vital organs, which can be 
checked through biochemical estimation without sacrifice 
the rat. For liver function assessment mainly used the 
SGOT, SGPT and ALP however for kidney function 
assessments mainly used urea and creatinine. After intake 
of any compound or molecules if any changes have been 
seen in above mentioned biomarkers from normal range, 
showed the toxicity of the compounds or molecules 
(Kuatsienu, Ansah, Adinortey, 2017).
TABLE I - Behavioral responses and general appearance of rat treated with single dose of AERI in acute toxicity study
Observation Control group 50 mg/kg 250 mg/kg 500 mg/kg 1000 mg/kg 2000 mg/kg 5000 mg/kg
Temperature Normal Normal Normal Normal Normal Normal Normal
Change in skin No effect No effect No effect No effect No effect No effect No effect
Eye color 
change
No effect No effect No effect No effect No effect No effect No effect
Food intake Normal Normal Normal Normal Normal Normal Normal
General 
physique
Normal Normal Normal Normal Normal Normal Normal
Diarrhea Not present Not present Not present Not present Not present Not present Not present
Coma Not present Not present Not present Not present Not present Not present Not present
Drowsiness Not present Not present Not present Not present Not present Not present Not present
Breathing 
difficulty
not observed not observed not observed not observed not observed not observed not observed
Sedation No effect No effect No effect No effect No effect Observed Observed
Tremor Not present Not present Not present Not present Not present Not present Not present
Death Alive Alive Alive Alive Alive Alive Alive
TABLE II - Effect of AERI on food intake and water consumption 
by rat during 28 days treatment and recovery period (satellite 
group)
Treatment
Average food 
intake 
(g/da/rat)
Average water 
intake 
(mL/day/rat
Control 4.29 ± 1.90 4.81 ± 1.20
50 mg/kg 4.52 ± 1.61 3.81 ± 1.94
250 mg/kg 4.89 ± 1.31 4.26 ± 1.92
500 mg/kg 3.28 ± 1.02 4.26 ± 1.68
1000 mg/kg 4.24 ± 1.08 4.65 ± 1.32
2000 mg/kg 4.39 ± 1.94 4.83 ± 1.53
Satellite control 4.23 ± 1.56 4.12 ± 1.81
Satellite (2000 mg/kg) 4.45 ± 1.71 4.91 ± 1.01
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TABLE III - Hematological parameters of rat treated with the different dose level of AERI in sub-acute toxicity after 14th day
Parameter Normal range Control 50 mg/kg 250 mg/kg 500 mg/kg 1000 mg/kg 2000 mg/kg Satellite
Hemoglobin 
(%)
10.2-46.6 15.73±1.48 14.11±1.08 14.41±1.56 13.65±0.39 14.65±1.84 13.59±1.21 15.15±1.08
Toat RBC (106/
µL)
5-10 9.14±0.29 9.80±0.65 9.40±0.14 9.83±0.27 9.93±0.47 9.02±0.07 9.90±0.77
WBC (103/µL) 6-15 11.41±2.42 9.08±2.96 9.05±0.16 10.68±1.32 8.17±1.28 9.29±1.50 13.56±1.08
Platelets 
(103/L)
782-985 909.30±22.04 862.06±51.55 895.17±80.75 908.50±60.85 920.77±44.17 931.18±23.42 981.16±70.16
PVC (%) 39-49 48.05±1.23 45.16±3.01 44.58±2.05 41.90±2.04 42.13±2.02 44.32±1.05 48.89±1.14
LC (%) 55-95 71.09±1.52 74.38±4.36 72.24±1.06 72.91±2.06 77.78±1.98 84.39±2.13 93.03±1.23
NP (%) 10-40 13.23±1.64 14.48±3.60 14.04±3.16 60.41±1.14 16.15±2.06 23.58±2.16 36.90±5.20
MV (%) 1-4 1.05±0.01 1.28±0.25 1.18±1.30 1.38±0.28 2.23±0.06 1.82±0.18 2.95±0.88
EP (%) 0-4 1.86±0.84 1.06±0.28 1.40±0.30 1.12±0.90 2.09±0.08 2.02±0.19 2.90±0.84
TABLE IV - Hematological parameters of rat treated with different dose level of AERI in sub-acute toxicity after 28th day
Parameter Normal range Control 50 mg/kg 250 mg/kg 500 mg/kg 1000 mg/kg 2000 mg/kg Satellite
Hemoglobin (%) 10.2-46.6 16.02±1.91 14.64±1.62 15.60±0.79 14.83±1.24 15.84±1.72 14.07±1.96 15.15±1.08
Toat RBC  
(106/µL)
5-10 10.90±0.07 9.88±0.45 9.84±0.25 9.93±0.05 9.98±0.82 9.54±0.65 9.90±0.77
WBC (103/µL) 6-15 12.94±1.74 9.85±0.69 10.02±0.49 1384±1.73 11.63±0.49 10.04±1.18 13.56±1.08
Platelets (103/L) 782-985 922.70±34.02 959.17±63.22 900.15±84.89 885.11±49.56 881.92±46.11 977.56±70.56 981.16±70.16
PVC (%) 39-49 49.9±2.16 47.15±1.22 46.50±2.14 44.64±3.18 45.07±1.09 46.89±2.41 48.89±1.41
LC (%) 55-95 76.10±3.68 78.43±3.58 73.59±2.15 77.54±2.98 89.98±2.17 91.03±3.23 93.03±1.23
NP (%) 10-40 25.32±1.88 23.12±1.80 28.50±1.10 33.66±1.12 13.34±2.89 32.89±1.28 369.90±5.20
MV (%) 1-4 1.50±0.15 1.53±0.16 1.48±0.12 2.05±0.15 2.36±0.12 2.19±0.54 2.95±0.88
EP (%) 0-4 1.93±0.11 1.90±0.35 1.94±0.38 1.97±0.73 2.80±0.61 2.69±0.24 2.90±0.84
TABLE V - Biochemical estimation from blood serum of rats after 14th day’s treatment at the different dose level in the subacute 
toxicity study
Parameter Normal range Control 50 mg/kg 250 mg/kg 500 mg/kg 1000 mg/kg 2000 mg/kg Satellite
SGOT (U/L) 54-298 153.6±16.70 155.33±20.49 163±33.34 162.5±35.21 163.33±33.59 215.5±33.59 99.02±3.09
SGPT (U/L) 17-77 43.5±7.77 43±9.9 38.16±4.68 49.16±6.06 42±8.72 51.16±7.72 49.57±0.19
ALP (U/L) 64-128 87.83±10 97.66±7.56 94.16±9.21 97.83±8.68 90.16±5.98 93±7.93 103.97±3.18
Creatinine  
(mg/dL)
0.2-0.9 0.34±0.035 0.36±0.04 0.34±0.04 0.35±0.03 0.35±0.02 0.36±0.02 0.28±0.026
Urea (U/L) 35-96 52.5±5.07 56.5±6.9 59.5±6.4 76±5.76 52±4.18 57.5±6.31 43±5.41
BUN (mg/dL) 8-33 24.51±2.36 26.38±3.23 27.78±2.98 32.06±4.02 24.28±1.95 26.85±2.94 20.08±2.47
The results suggested from our study that the levels 
or activities of biochemical parameters in animals after 14th 
& 28th days and found no significant variations occurred 
in SGOT, SGPT, ALP, Urea and creatinine levels at all 
tested doses in comparison to control. The satellite group 
after 6 weeks also showed the no significant changes in 
the above mentioned biochemical with compare to control 
(Table V and Table VI) 
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Histopathology
In the histopathological study, we found that in 
all treated groups after 14 days (Figure 2) and 28 days 
(Figure 3) the organs showed no changes at cellular 
level in comparison to control. The histopathology slides 
also confirmed the AERI treated group up to the dose of 
2000 mg/kg showed no toxicity in 4 weeks.
Estimated dose
The 1/10th and 1/20th of maximum dose from 
TABLE VI - Biochemical estimation from blood serum of rats after 28th day’s treatment at different dose level in sub- acute toxicity 
study
Parameter Normal range Control 50 mg/kg 250 mg/kg 500 mg/kg 1000 mg/kg 2000 mg/kg Satellite
SGOT (U/L) 54-298 163.5±32.5 167.16±32.74 183.33±24.8 178.66±19.2 192.5±35.47 208.66±15.99 99.02±3.09
SGPT (U/L) 17-77 45.5±8.65 46±7.94 39.83±6.19 59.33±6.15 46.66±7.27 53.5±7.18 49.57±0.19
ALP (U/L) 64-128 95.33±6.71 101±7.5 97.66±9.13 106.16±5.59 99.5±3.39 111.16±9.3 103.97±3.18
Creatinine 
(mg/dL)
0.2-0.9 0.39±0.05 0.38±0.023 0.47±0.05 0.8±0.04 0.44±0.05 0.45±0.02 0.28±0.026
Urea (U/L) 35-96 65.16±5.66 68.66±8.61 66.83±6.71 81±6.22 61.66±6.09 65.66±8.85 43±5.41
BUN (mg/dL) 8-33 30.43±2.64 37.82±2.9 32.21±3.13 35.49±2.69 28.79±2.84 30.66±4.13 20.08±2.47
FIGURE 1 - Body weight assessment of treated rats in sub-acute 
toxicity study.
FIGURE 2 - Histopathology (H&E stain10x) of rat tissues of treated groups rats after 14th days.
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FIGURE 3 - Histopathology (H&E stain10x) of rat tissues of treated groups rats after 28th days.
toxicity assessment study were taken and the estimated 
dose for animal would be 500 and 250mg/kg. The 
human equivalent dose from 500 and 250mg/kg body 
wt. dose of animal would be 81.08 mg/kg and 40.54 mg/
kg. Considering average human body wt. of 60kg, the 
estimated daily dose would be 4.801 gm/day. The data 
may be helpful for further study of this extract on animal. 
The estimated human daily dose may be used for clinical 
study of the extract.
CONCLUSIONS
The oral dose of maximum 5000 mg/kg of the 
alcoholic extract of leaves Reinwardtia indica showed 
no treatment-related signs of toxicity or mortality. In the 
repeated dose for 28-day, the oral administration at the 
different dose level of AERI up to 2000 mg/kg showed no 
significant changes in intake of food & water, haematology, 
biochemical serum analysis and histopathology at the 
cellular level. It is clearly indicated that the AERI can be 
used for further evaluation of pharmacological activities 
on the above mentioned dose of extract.
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